ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
255.82
+3.27 (1.29%)
Feb 17, 2026, 4:00 PM EST - Market closed
ResMed Stock Forecast
Stock Price Forecast
The 10 analysts that cover ResMed stock have a consensus rating of "Buy" and an average price target of $293.7, which forecasts a 14.81% increase in the stock price over the next year. The lowest target is $265 and the highest is $345.
Price Target: $293.7 (+14.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 6 | 5 | 5 | 5 |
| Hold | 3 | 4 | 4 | 5 | 5 | 4 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $330 → $345 | Strong Buy | Maintains | $330 → $345 | +34.86% | Feb 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $311 → $314 | Buy | Maintains | $311 → $314 | +22.74% | Jan 30, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $270 → $275 | Hold | Maintains | $270 → $275 | +7.50% | Jan 30, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $265 → $270 | Hold | Maintains | $265 → $270 | +5.54% | Jan 30, 2026 |
| Stifel | Stifel | Hold Maintains $260 → $265 | Hold | Maintains | $260 → $265 | +3.59% | Jan 30, 2026 |
Financial Forecast
Revenue This Year
5.69B
from 5.15B
Increased by 10.64%
Revenue Next Year
6.11B
from 5.69B
Increased by 7.38%
EPS This Year
11.12
from 9.51
Increased by 16.89%
EPS Next Year
12.28
from 11.12
Increased by 10.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.0B | 6.5B | |||
| Avg | 5.7B | 6.1B | |||
| Low | 5.5B | 5.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.8% | 13.8% | |||
| Avg | 10.6% | 7.4% | |||
| Low | 6.6% | 2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.78 | 13.40 | |||
| Avg | 11.12 | 12.28 | |||
| Low | 10.14 | 11.47 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.9% | 20.5% | |||
| Avg | 16.9% | 10.5% | |||
| Low | 6.7% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.